Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Optimal Radiation Dose for Stage III Lung Cancer-Should "Definitive" Radiation Doses Be Used in the Preoperative Setting?
JTO Clin Res Rep
August 2021
Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
Introduction: There are currently two recommended radiation strategies for clinical stage III NSCLC: a lower "preoperative" (45-54 Gy) and a higher "definitive/nonsurgical" (60-70 Gy) dose. We sought to determine if definitive radiation doses should be used in the preoperative setting given that many clinical stage III patients planned for surgery are ultimately managed with chemoradiation alone.
Methods: Using the National Cancer Database data from 2006 to 2016, we performed a comparative effectiveness analysis of stage III N2 patients who received chemoradiotherapy.
[Lung cancer--should positron-emission tomography be used?].
Ugeskr Laeger
June 2004
H:S Rigshospitalet, Diagnostisk Center, Klinik for Klinisk Fysiologi og Nuklearmedicin, København.
Extended pneumonectomy for non small cell lung cancer--should we still do it?
Neoplasma
July 2004
Department of Thoracic Surgery, Karol Marcinkowski University of Medical Sciences, Poznan, Poland.
The aim of the study was to assess the early and late results of extended pneumonectomies in lung cancer patients with T3 and T4 disease. Between Jan. 1995 and Dec.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!